CC
TMO icon

Courier Capital’s Thermo Fisher Scientific TMO Stock Holding History

Courier Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
5,090
-7
-0.1% -$3.36K 0.13% 146
2026
Q1 		$2.51M Sell
5,097
-297
-6% -$161K 0.14% 143
2025
Q4 		$3.13M Sell
5,394
-2,027
-27% -$1.15M 0.18% 121
2025
Q3 		$1.72M Buy
7,421
+2,021
+37% +$941K 0.1% 175
2025
Q2 		$2.19M Sell
5,400
-1,885
-26% -$788K 0.13% 143
2025
Q1 		$3.63M Sell
7,285
-13,629
-65% -$7.38M 0.24% 105
2024
Q4 		$6.39M Buy
20,914
+12,509
+149% +$6.88M 0.44% 57
2024
Q3 		$5.2M Buy
8,405
+7,470
+799% +$4.42M 0.36% 71
2024
Q2 		$517K Sell
935
-7,752
-89% -$4.44M 0.04% 219
2024
Q1 		$5.05M Sell
8,687
-10,534
-55% -$5.91M 0.37% 69
2023
Q4 		$6.45M Sell
19,221
-95
-0.5% -$46K 0.49% 51
2023
Q3 		$6.17M Buy
19,316
+10,309
+114% +$5.49M 0.51% 50
2023
Q2 		$4.7M Buy
9,007
+8,171
+977% +$4.41M 0.37% 62
2023
Q1 		$482K Hold
836
– – 0.05% 181
2022
Q4 		$460K Sell
836
-111
-12% -$58.8K 0.05% 187
2022
Q3 		$480K Buy
947
+31
+3% +$17.3K 0.06% 171
2022
Q2 		$498K Buy
916
+50
+6% +$27.5K 0.06% 172
2022
Q1 		$512K Hold
866
– – 0.05% 182
2021
Q4 		$578K Sell
866
-6
-0.7% -$3.75K 0.05% 177
2021
Q3 		$498K Hold
872
– – 0.05% 185
2021
Q2 		$440K Sell
872
-85
-9% -$40.1K 0.04% 198
2021
Q1 		$437K Sell
957
-653
-41% -$312K 0.04% 198
2020
Q4 		$750K Sell
1,610
-142
-8% -$66.6K 0.08% 140
2020
Q3 		$925K Buy
1,752
+199
+13% +$82.2K 0.11% 121
2020
Q2 		$568K Hold
1,553
– – 0.07% 151
2020
Q1 		$496K Sell
1,553
-229
-13% -$72.2K 0.07% 143
2019
Q4 		$587K Sell
1,782
-70
-4% -$21.2K 0.07% 157
2019
Q3 		$524K Hold
1,852
– – 0.07% 163
2019
Q2 		$544K Buy
1,852
+761
+70% +$210K 0.07% 158
2019
Q1 		$299K Hold
1,091
– – 0.04% 217
2018
Q4 		$244K Hold
1,091
– – 0.04% 226
2018
Q3 		$266K Buy
1,091
+55
+5% +$12.7K 0.03% 237
2018
Q2 		$215K Hold
1,036
– – 0.03% 270
2018
Q1 		$214K Sell
1,036
-100
-9% -$21K 0.03% 274
2017
Q4 		$216K Hold
1,136
– – 0.03% 277
2017
Q3 		$215K Sell
1,136
-27
-2% -$4.89K 0.03% 267
2017
Q2 		$203K Buy
+1,163
New +$195K 0.03% 266
2016
Q4 		– Sell
-1,716
Closed -$273K – 273
2016
Q3 		$273K Sell
1,716
-740
-30% -$114K 0.05% 220
2016
Q2 		$363K Hold
2,456
– – 0.07% 194
2016
Q1 		$348K Buy
2,456
+280
+13% +$37.5K 0.07% 191
2015
Q4 		$309K Buy
2,176
+390
+22% +$52K 0.07% 203
2015
Q3 		$218K Buy
+1,786
New +$233K 0.05% 234
2013
Q4 		– Sell
-2,481
Closed -$229K – 293
2013
Q3 		$229K Buy
2,481
+18
+0.7% +$1.63K 0.05% 239
2013
Q2 		$208K Buy
+2,463
New +$205K 0.05% 253

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Courier Capital's TMO Position: Q2 2026 in Review

Courier Capital reduced its Thermo Fisher Scientific (TMO) stake by 0.14% in Q2 2026, selling an estimated $3.36K and leaving 5,090 shares worth $2.55M. The position accounts for 0.13% of the portfolio, ranked #146.

Courier Capital first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $6.45M in Q4 2023. 1,139 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Courier Capital held 5,090 shares of Thermo Fisher Scientific worth $2.55M as of Q2 2026.
  • Courier Capital sold 7 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.36K.
  • Thermo Fisher Scientific made up 0.13% of Courier Capital's portfolio in Q2 2026, its #146 holding.
  • Courier Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
  • Courier Capital's Thermo Fisher Scientific position peaked at $6.45M in Q4 2023.
  • 1,139 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.